+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Vaccines Market - Forecast (2020 - 2025)

  • ID: 3501341
  • Report
  • March 2020
  • Region: Global
  • 117 pages
  • IndustryARC
1 of 3
Veterinary Vaccines Market Overview:

According to the findings by the International Federation for Animal Health, 61% of animal diseases are zoonotic, meaning they have the potential to cause human pandemics. Thus, veterinary vaccines are gaining traction as an imperative implementation for protecting animal health as well as public health as they effectively mimic the naturally acquired immunity. Increasing livestock population catering to feed the colossal non-vegetarian population coupled with the adoption of companion animals by the majority of households in developing as well as developed countries is disrupting the veterinary vaccines market. Technological advancements in vaccines, increasing consciousness concerning animal health, increasing investments by government bodies and associations, and augmented demand for animal based protein has driven this arcade to reach a staggering market size of $7.5 billion as of 2020, and the demand is estimated to increment at formidable compound annual growth rate (CAGR) of 8.2% during the forecast period of 2020 to 2025.

Veterinary Vaccines Market Outlook:

Economic Relief by Veterinary Vaccines-

Apart from being zoonotic, animal contagious diseases have rampant tendency to ubiquitously disrupt the economic stability of livestock production. As per the Federation of American Scientists, an epidemic of mad-cow disease in England in the 1990s cost $9 billion - $14 billion as compensation to agrarians, and additional $2.4 billion from loss of export marketplaces.

As the livestock production accounts for nearly 40% of the global agricultural production value and is an integral source of nutrition for an estimated 9 billion population by 2050, veterinary vaccines market has found a major employer in this segment as animal diseases hamper efficient production and sources economic turbulence. Some of the transboundary animal diseases highly distressing the livestock sector commercial constancy are foot-and-mouth disease (FMD), H5N1 highly pathogenic avian influenza (HPAI), avian influenza (AI), lumpy skin disease (LSD), and Newcastle Disease.

After an acute analysis of the regional veterinary vaccines market share, North America was reckoned to be the dominating region securing the apex spot in terms of generating veterinary vaccines demand. This region accounts for 32% of the global veterinary vaccines market size as of 2020. The sheer affluence can be attributed to established vaccination programs and rise in ownership of pet animals. As per the National Pet Owners Survey conducted by the American Pet Products Association (APPA) 2020-2020, 68% of the U.S families own a pet with 60.2 million household housing a companion dog. The United States Department of Agriculture (USDA) Center for Veterinary Biologics controls and authorize veterinary rabies vaccines. Some of the other canine vaccines include canine distemper, canine parvovirus, infectious canine hepatitis, adenovirus-2, leptospirosis, bordatella, canine parainfluenza virus, and Lyme disease. National Association of State Public Health Veterinarians, oversees vaccination and USDA-licensed vaccines. Thus, all these factor resonates the well-established veterinary healthcare facility disrupting the North America veterinary vaccines market growth.

There are several variants of vaccines designed for different kinds of diseases, such as veterinary viral vaccines, veterinary bacterial vaccines and veterinary parasite vaccines. Among these, live viral vaccines is the most dominant type flourishing at an application CAGR of 9.0% going through 2025. Live vaccines use an attenuated form of the germ that sources an infection. Owing to its peculiarities being identical to the natural contagion that they help in preventing, such vaccines create a resilient and enduring immune response. For instance, in 2020 Merck Animal Health pioneered the INNOVAX-ND-IBD, the first live vaccine curated with biotechnology that safeguards chickens from Newcastle Disease, transmittable bursal disease, and Marek’s ailment.

Veterinary Vaccines Market Trends and Growth Drivers:

Virus-like particle (VLP)-based vaccines- Some viral proteins can instinctively accumulate into biological nanoparticles, so-called ‘virus-like particles’. VLPs impersonates viral structures and are voluntarily acknowledged by the immune system, activating an enhanced immune reaction. Noticeable samples of VLP-based vaccines are some baculovirus/insect cell-expressed veterinary vaccines against Porcine circovirus 2 (PCV2), Ingelvac CircoFLEX® for example.

Modern developments in the study of virulence and pathogenicity amalgamated with operational molecular biological approaches have augmented the balanced design of vaccines, where virulence aspects have been controllably eradicated or functionally muted. This has headed to vaccines that uphold the useful properties of live vaccines while decreasing the threat for a possible reversion of virulence. A sample of this technology is a vaccine against Bovine viral diarrhoea virus (BVBD) recently introduced in the EU (Bovela).

Veterinary Vaccines Market Players Perspective:

Veterinary vaccines market is a flourishing arcade with players implementing biological and inorganic development policies to amplify their product offerings, reinforce their terrestrial spread, increase customer reach, increase substantial marketplace share and enhance veterinary vaccine development.

Some of the key players profiled in this report are Boehringer Ingelheim GmbH, Merck Animal Health, Zoetis Inc., Eli Lilly and Company, Bayer AG (Bayer Animal Health), Ceva Sant? Animale, Virbac, Biovac, Neogen Corporation, and ImmuCell Corporation.

December 2020, Prondil S.A., a developer and manufacturer of animal health vaccines for livestock was acquired by Merck Animal Health. This procurement aided Merck Animal Health to develop more progressive vaccines for a livestock animal in order to extend its market towards livestock sector.

Veterinary Vaccines Market Scope:

The base year of the study is 2020, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the veterinary vaccines market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various vaccines types in veterinary vaccines market, and their specific advantages.

Veterinary Vaccines Market Report: Industry Coverage

  • By Type: Veterinary Viral Vaccines, Veterinary Bacterial Vaccines, Veterinary Parasite Vaccines, Others
  • By Type of Disease: Bovine Vaccines, Feline Vaccines, Canine Vaccines, Poultry Vaccines, Equine Vaccines
  • By Geography: Americas, Europe, APAC, ROW

The Veterinary Vaccines Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions.

The regions and countries covered in the study include:

  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia

Key Questions Addressed in the Veterinary Vaccines Market Report

  • Is the market for the veterinary vaccines growing? How long will it continue to grow and at what rate?
  • Which type of systems presents the major growth opportunities?
  • Is there a possibility for change in the market structure over time?
  • Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands?
  • Do the key vendors look for partnerships to expand their businesses with respect to geography or product?
  • What are the short-term, long-term, and medium-term growth drivers for the market?
  • What are the short-term, medium-term, and long-term challenges for the market?
  • What are the short-term, medium-term, and long-term opportunities for the market
  • Who are the top players/companies of the market?
  • What are the recent innovations in the market?
  • How many patents have been filed by the leading players?
  • What are the types of patents filed by the leading players?
  • What is our Vision 2030 for veterinary vaccines market?

A few focus points of this Research are given below:

  • Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies
  • Provide an overview of the product portfolio, including product planning, development, and positioning
  • Discuss the role of technology companies in partnerships
  • Explore the regional sales activities
  • Analyze the market size and giving the forecast for current and future veterinary vaccines during the forecast 2020–2025
  • Analyze the competitive factors, competitors’ market shares, product capabilities, and supply chain structures.

Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Veterinary Vaccines Market - Overview
1.1. Definitions and Scope

2. Veterinary Vaccines Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography

3. Veterinary Vaccines Market
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis

4. Veterinary Vaccines Market Forces
4.1. Drivers
4.2. Constraints
4.3. Challenges
4.4. Porters five force model
4.4.1. Bargaining power of suppliers
4.4.2. Bargaining powers of customers
4.4.3. Threat of new entrants
4.4.4. Rivalry among existing players
4.4.5. Threat of substitutes

5. Veterinary Vaccines Market -Strategic analysis
5.1. Value chain analysis
5.2. Opportunities analysis
5.3. Product life cycle
5.4. Suppliers and distributors Market Share

6. Veterinary Vaccines Market – By Type (Market Size -$Million / $Billion)
6.1. Market Size and Market Share Analysis
6.2. Application Revenue and Trend Research
6.3. Product Segment Analysis
6.3.1. Veterinary Viral Vaccines
6.3.1.1. Live Viral Vaccines
6.3.1.2. Inactivated Viral Vaccines
6.3.1.3. DIVA Vaccines (Differentiating Infected from Vaccinated Animals)
6.3.1.4. Molecularly Defined Subunit Vaccines
6.3.1.5. Genetically Engineered Viral Vaccines
6.3.1.6.3. Live Viral Vector Vaccines
6.3.1.5. DNA Vaccines
6.3.2. Veterinary Bacterial Vaccines
6.3.2.1. Conventional Live Vaccines
6.3.2.2. Conventional Inactivated Vaccines
6.3.2.3. Gene-Deleted Vaccines
6.3.2.4. Subunit Vaccines
6.3.3. Veterinary Parasite Vaccines
6.3.3.1. Protozoal Vaccines
6.3.3.2. Subunit Protozoal Parasite Vaccines
6.3.3.3. Helminth and Ectoparasite Vaccines
6.3.4. Veterinary Vaccines for Infectious Diseases
6.3.4.1. Allergy Vaccines
6.3.4.2. Cancer Vaccines

7. Veterinary Vaccines Market – By Type of Disease (Market Size -$Million / $Billion)
7.1. Bovine Vaccines
7.1.1. Bovine Viral Diarrhea
7.1.2. Brucellosis
7.1.3. Foot and Mouth Disease
7.1.4. Bovine Clostridial Disease
7.1.5. Infectious Bovine Rhinotracheitis
7.2. Porcine Vaccines
7.2.1. Porcine Parvovirus
7.2.2. Porcine Reproductive Respiratory Syndrome
7.2.3. Porcine Circovirus II
7.2.4. Swine Influenza
7.2.5. Auzeszky’s Disease
7.2.4. Swine Pneumonia
7.3. Feline Vaccines
7.3.1. Feline Rabies
7.3.2. Feline Panleukopenia
7.3.3. Feline Leukemia
7.4. Canine Vaccines
7.4.1. Canine Rabies
7.4.2. Canine Distemper
7.4.3. Canine Parvovirus
7.5. Poultry Vaccines
7.5.1. Infectious Bronchitis
7.5.2. Gumboro Disease
7.5.3. Avian Influenza
7.5.4. Coccidiosis
7.5.5. Mycoplasma
7.5.4. Newcastle Disease
7.5.7. Marek’s Disease
7.4. Equine Vaccines
7.4.1. Strangles
7.4.2. Equine Influenza
7.4.3. Equine Encephalomyelitis
7.4.4. Tetanus
7.4.5. Equine Rhinopneumonitis

8. Veterinary Vaccines - By Geography (Market Size -$Million / $Billion)
8.1. Veterinary Vaccines Market - North America Segment Research
8.2. North America Market Research (Million / $Billion)
8.2.1. Segment type Size and Market Size Analysis
8.2.2. Revenue and Trends
8.2.3. Application Revenue and Trends by type of Application
8.2.4. Company Revenue and Product Analysis
8.2.5. North America Product type and Application Market Size
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.2.5.4. Rest of North America
8.3. Veterinary Vaccines - South America Segment Research
8.4. South America Market Research (Market Size -$Million / $Billion)
8.4.1. Segment type Size and Market Size Analysis
8.4.2. Revenue and Trends
8.4.3. Application Revenue and Trends by type of Application
8.4.4. Company Revenue and Product Analysis
8.4.5. South America Product type and Application Market Size
8.4.5.1. Brazil
8.4.5.2. Venezuela
8.4.5.3. Argentina
8.4.5.4. Ecuador
8.4.5.5. Peru
8.4.5.4. Colombia
8.4.5.5. Costa Rica
8.4.5.8. Rest of South America
8.5. Veterinary Vaccines - Europe Segment Research
8.4. Europe Market Research (Market Size -$Million / $Billion)
8.4.1. Segment type Size and Market Size Analysis
8.4.2. Revenue and Trends
8.4.3. Application Revenue and Trends by type of Application
8.4.4. Company Revenue and Product Analysis
8.4.5. Europe Segment Product type and Application Market Size
8.4.5.1. U.K
8.4.5.2. Germany
8.4.5.3. Italy
8.4.5.4. France
8.4.5.5. Netherlands
8.4.5.4. Belgium
8.4.5.5. Spain
8.4.5.8. Denmark
8.4.5.9. Rest of Europe
8.5. Veterinary Vaccines – APAC Segment Research
8.8. APAC Market Research (Market Size -$Million / $Billion)
8.8.1. Segment type Size and Market Size Analysis
8.8.2. Revenue and Trends
8.8.3. Application Revenue and Trends by type of Application
8.8.4. Company Revenue and Product Analysis
8.8.5. APAC Segment – Product type and Application Market Size
8.8.5.1. China
8.8.5.2. Australia
8.8.5.3. Japan
8.8.5.4. South Korea
8.8.5.5. India
8.8.5.4. Taiwan
8.8.5.5. Malaysia

9. Veterinary Vaccines Market - Entropy
9.1. New product launches
9.2. M&A's, collaborations, JVs and partnerships

10. Veterinary Vaccines Market Company Analysis
10.1. Market Share, Company Revenue, Products, M&A, Developments
10.2. Zoetis
10.3. Merck Animal Health
10.4. Ceva Animal Health
10.5. Boehringer Ingelheim
10.4. Heska Corporation

11. Veterinary Vaccines Market -Appendix
11.1. Abbreviations
11.2. Sources
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

Loading
LOADING...

Adroll
adroll